Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Insights into the modular design of kinase inhibitors and application to Abl and Axl.
RSC Med Chem. 2021 Nov 5;13(1):64-71. doi: 10.1039/d1md00296a. eCollection 2022 Jan 27.
RSC Med Chem. 2021.
PMID: 35224497
Free PMC article.
Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase.
Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB.
Johnson TK, et al. Among authors: vandecan nm.
Angew Chem Int Ed Engl. 2021 Sep 6;60(37):20196-20199. doi: 10.1002/anie.202105351. Epub 2021 Aug 11.
Angew Chem Int Ed Engl. 2021.
PMID: 34292655
Free PMC article.
Item in Clipboard
Molecular determinants of drug response in TNBC cell lines.
Merrill NM, Lachacz EJ, Vandecan NM, Ulintz PJ, Bao L, Lloyd JP, Yates JA, Morikawa A, Merajver SD, Soellner MB.
Merrill NM, et al. Among authors: vandecan nm.
Breast Cancer Res Treat. 2020 Jan;179(2):337-347. doi: 10.1007/s10549-019-05473-9. Epub 2019 Oct 26.
Breast Cancer Res Treat. 2020.
PMID: 31655920
Free PMC article.
Item in Clipboard
MEK is a promising target in the basal subtype of bladder cancer.
Merrill NM, Vandecan NM, Day KC, Palmbos PL, Day ML, Udager AM, Merajver SD, Soellner MB.
Merrill NM, et al. Among authors: vandecan nm.
Oncotarget. 2020 Nov 3;11(44):3921-3932. doi: 10.18632/oncotarget.27767. eCollection 2020 Nov 3.
Oncotarget. 2020.
PMID: 33216841
Free PMC article.
Item in Clipboard
Selective and Potent PROTAC Degraders of c-Src Kinase.
Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB.
Mao W, et al. Among authors: vandecan nm.
ACS Chem Biol. 2024 Jan 19;19(1):110-116. doi: 10.1021/acschembio.3c00548. Epub 2023 Dec 19.
ACS Chem Biol. 2024.
PMID: 38113191
Item in Clipboard
Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase".
Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB.
Johnson TK, et al. Among authors: vandecan nm.
Angew Chem Int Ed Engl. 2022 Nov 14;61(46):e202209518. doi: 10.1002/anie.202209518. Epub 2022 Oct 25.
Angew Chem Int Ed Engl. 2022.
PMID: 36283971
Item in Clipboard
Cite
Cite